HNRPD_HUMAN - dbPTM
HNRPD_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID HNRPD_HUMAN
UniProt AC Q14103
Protein Name Heterogeneous nuclear ribonucleoprotein D0
Gene Name HNRNPD
Organism Homo sapiens (Human).
Sequence Length 355
Subcellular Localization Nucleus. Cytoplasm. Localized in cytoplasmic mRNP granules containing untranslated mRNAs. Component of ribonucleosomes. Cytoplasmic localization oscillates diurnally.
Protein Description Binds with high affinity to RNA molecules that contain AU-rich elements (AREs) found within the 3'-UTR of many proto-oncogenes and cytokine mRNAs. Also binds to double- and single-stranded DNA sequences in a specific manner and functions a transcription factor. Each of the RNA-binding domains specifically can bind solely to a single-stranded non-monotonous 5'-UUAG-3' sequence and also weaker to the single-stranded 5'-TTAGGG-3' telomeric DNA repeat. Binds RNA oligonucleotides with 5'-UUAGGG-3' repeats more tightly than the telomeric single-stranded DNA 5'-TTAGGG-3' repeats. Binding of RRM1 to DNA inhibits the formation of DNA quadruplex structure which may play a role in telomere elongation. May be involved in translationally coupled mRNA turnover. Implicated with other RNA-binding proteins in the cytoplasmic deadenylation/translational and decay interplay of the FOS mRNA mediated by the major coding-region determinant of instability (mCRD) domain. May play a role in the regulation of the rhythmic expression of circadian clock core genes. Directly binds to the 3'UTR of CRY1 mRNA and induces CRY1 rhythmic translation. May also be involved in the regulation of PER2 translation..
Protein Sequence MSEEQFGGDGAAAAATAAVGGSAGEQEGAMVAATQGAAAAAGSGAGTGGGTASGGTEGGSAESEGAKIDASKNEEDEGHSNSSPRHSEAATAQREEWKMFIGGLSWDTTKKDLKDYFSKFGEVVDCTLKLDPITGRSRGFGFVLFKESESVDKVMDQKEHKLNGKVIDPKRAKAMKTKEPVKKIFVGGLSPDTPEEKIREYFGGFGEVESIELPMDNKTNKRRGFCFITFKEEEPVKKIMEKKYHNVGLSKCEIKVAMSKEQYQQQQQWGSRGGFAGRARGRGGGPSQNWNQGYSNYWNQGYGNYGYNSQGYGGYGGYDYTGYNNYYGYGDYSNQQSGYGKVSRRGGHQNSYKPY
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MSEEQFGGD
------CCHHHCCCH
50.2519413330
2Phosphorylation------MSEEQFGGD
------CCHHHCCCH
50.2519413330
16PhosphorylationDGAAAAATAAVGGSA
HHHHHHHHHHHCCCH
15.4927251275
22PhosphorylationATAAVGGSAGEQEGA
HHHHHCCCHHHHHHH
27.4621601212
34PhosphorylationEGAMVAATQGAAAAA
HHHHEHHHCHHHHHC
20.1427251275
43PhosphorylationGAAAAAGSGAGTGGG
HHHHHCCCCCCCCCC
22.2727251275
47PhosphorylationAAGSGAGTGGGTASG
HCCCCCCCCCCCCCC
31.9227251275
51PhosphorylationGAGTGGGTASGGTEG
CCCCCCCCCCCCCCC
22.4127251275
56PhosphorylationGGTASGGTEGGSAES
CCCCCCCCCCCCCCC
34.6824505115
60PhosphorylationSGGTEGGSAESEGAK
CCCCCCCCCCCCCCC
39.4522817901
63PhosphorylationTEGGSAESEGAKIDA
CCCCCCCCCCCCCCC
40.8422817901
71PhosphorylationEGAKIDASKNEEDEG
CCCCCCCCCCCCCCC
32.0629255136
72AcetylationGAKIDASKNEEDEGH
CCCCCCCCCCCCCCC
70.8323749302
72UbiquitinationGAKIDASKNEEDEGH
CCCCCCCCCCCCCCC
70.8321906983
72SumoylationGAKIDASKNEEDEGH
CCCCCCCCCCCCCCC
70.8328112733
72 (in isoform 1)Ubiquitination-70.8321890473
72 (in isoform 3)Ubiquitination-70.8321890473
80PhosphorylationNEEDEGHSNSSPRHS
CCCCCCCCCCCHHHH
49.6229255136
82PhosphorylationEDEGHSNSSPRHSEA
CCCCCCCCCHHHHHH
44.7429255136
83PhosphorylationDEGHSNSSPRHSEAA
CCCCCCCCHHHHHHH
30.1529255136
87PhosphorylationSNSSPRHSEAATAQR
CCCCHHHHHHHHHCH
30.1529255136
91PhosphorylationPRHSEAATAQREEWK
HHHHHHHHHCHHHHH
30.3030266825
91 (in isoform 2)Ubiquitination-30.3021890473
91 (in isoform 4)Ubiquitination-30.3021890473
94MethylationSEAATAQREEWKMFI
HHHHHHCHHHHHHHH
41.14115386471
95 (in isoform 2)Ubiquitination-57.0121890473
95 (in isoform 4)Ubiquitination-57.0121890473
98AcetylationTAQREEWKMFIGGLS
HHCHHHHHHHHCCCC
27.4925953088
99SulfoxidationAQREEWKMFIGGLSW
HCHHHHHHHHCCCCC
2.8728183972
100 (in isoform 2)Ubiquitination-4.1021890473
100 (in isoform 4)Ubiquitination-4.1021890473
105PhosphorylationKMFIGGLSWDTTKKD
HHHHCCCCCCCCHHH
26.61-
108PhosphorylationIGGLSWDTTKKDLKD
HCCCCCCCCHHHHHH
33.9719664994
110AcetylationGLSWDTTKKDLKDYF
CCCCCCCHHHHHHHH
46.5126051181
110UbiquitinationGLSWDTTKKDLKDYF
CCCCCCCHHHHHHHH
46.5121906983
110 (in isoform 3)Ubiquitination-46.5121890473
110 (in isoform 1)Ubiquitination-46.5121890473
110 (in isoform 2)Ubiquitination-46.5121890473
110 (in isoform 4)Ubiquitination-46.5121890473
111AcetylationLSWDTTKKDLKDYFS
CCCCCCHHHHHHHHH
67.2224469531
111UbiquitinationLSWDTTKKDLKDYFS
CCCCCCHHHHHHHHH
67.22-
111 (in isoform 3)Ubiquitination-67.22-
111MalonylationLSWDTTKKDLKDYFS
CCCCCCHHHHHHHHH
67.2226320211
114AcetylationDTTKKDLKDYFSKFG
CCCHHHHHHHHHHHC
61.5925825284
114UbiquitinationDTTKKDLKDYFSKFG
CCCHHHHHHHHHHHC
61.5921890473
114 (in isoform 3)Ubiquitination-61.5921890473
114SuccinylationDTTKKDLKDYFSKFG
CCCHHHHHHHHHHHC
61.5923954790
114 (in isoform 1)Ubiquitination-61.5921890473
116PhosphorylationTKKDLKDYFSKFGEV
CHHHHHHHHHHHCCE
14.2528152594
118PhosphorylationKDLKDYFSKFGEVVD
HHHHHHHHHHCCEEE
22.3528152594
119AcetylationDLKDYFSKFGEVVDC
HHHHHHHHHCCEEEE
47.7125825284
119MethylationDLKDYFSKFGEVVDC
HHHHHHHHHCCEEEE
47.7123161681
119UbiquitinationDLKDYFSKFGEVVDC
HHHHHHHHHCCEEEE
47.7121890473
119 (in isoform 3)Ubiquitination-47.7121890473
119 (in isoform 1)Ubiquitination-47.7121890473
126S-nitrosocysteineKFGEVVDCTLKLDPI
HHCCEEEEEEEECCC
3.03-
126GlutathionylationKFGEVVDCTLKLDPI
HHCCEEEEEEEECCC
3.0322555962
126S-nitrosylationKFGEVVDCTLKLDPI
HHCCEEEEEEEECCC
3.0319483679
127PhosphorylationFGEVVDCTLKLDPIT
HCCEEEEEEEECCCC
23.5919664994
129AcetylationEVVDCTLKLDPITGR
CEEEEEEEECCCCCC
32.4623749302
129UbiquitinationEVVDCTLKLDPITGR
CEEEEEEEECCCCCC
32.4622053931
129 (in isoform 3)Ubiquitination-32.4621890473
129MethylationEVVDCTLKLDPITGR
CEEEEEEEECCCCCC
32.4623583077
129SumoylationEVVDCTLKLDPITGR
CEEEEEEEECCCCCC
32.4628112733
129 (in isoform 1)Ubiquitination-32.4621890473
134PhosphorylationTLKLDPITGRSRGFG
EEEECCCCCCCCCEE
31.7523403867
137PhosphorylationLDPITGRSRGFGFVL
ECCCCCCCCCEEEEE
37.7924719451
138MethylationDPITGRSRGFGFVLF
CCCCCCCCCEEEEEE
43.00-
146AcetylationGFGFVLFKESESVDK
CEEEEEEECCCCHHH
57.0519608861
153AcetylationKESESVDKVMDQKEH
ECCCCHHHHHHHHHH
36.9923749302
153UbiquitinationKESESVDKVMDQKEH
ECCCCHHHHHHHHHH
36.99-
153 (in isoform 3)Ubiquitination-36.99-
155SulfoxidationSESVDKVMDQKEHKL
CCCHHHHHHHHHHHH
5.7921406390
158AcetylationVDKVMDQKEHKLNGK
HHHHHHHHHHHHCCE
58.4825953088
161 (in isoform 3)Ubiquitination-44.75-
164 (in isoform 2)Ubiquitination-35.7221890473
164 (in isoform 4)Ubiquitination-35.7221890473
165AcetylationKEHKLNGKVIDPKRA
HHHHHCCEECCHHHH
34.6419608861
165UbiquitinationKEHKLNGKVIDPKRA
HHHHHCCEECCHHHH
34.6419608861
165 (in isoform 3)Ubiquitination-34.64-
170UbiquitinationNGKVIDPKRAKAMKT
CCEECCHHHHHHCCC
62.33-
178 (in isoform 2)Ubiquitination-55.2821890473
178 (in isoform 4)Ubiquitination-55.2821890473
183UbiquitinationKTKEPVKKIFVGGLS
CCCCCCCEEECCCCC
41.4321890473
183MalonylationKTKEPVKKIFVGGLS
CCCCCCCEEECCCCC
41.4326320211
183AcetylationKTKEPVKKIFVGGLS
CCCCCCCEEECCCCC
41.4326051181
183 (in isoform 1)Ubiquitination-41.4321890473
183 (in isoform 3)Ubiquitination-41.4321890473
190PhosphorylationKIFVGGLSPDTPEEK
EEECCCCCCCCHHHH
24.8119664994
193PhosphorylationVGGLSPDTPEEKIRE
CCCCCCCCHHHHHHH
35.6629255136
197AcetylationSPDTPEEKIREYFGG
CCCCHHHHHHHHHCC
45.4623954790
197UbiquitinationSPDTPEEKIREYFGG
CCCCHHHHHHHHHCC
45.4621890473
197SumoylationSPDTPEEKIREYFGG
CCCCHHHHHHHHHCC
45.4628112733
197 (in isoform 3)Ubiquitination-45.4621890473
197MalonylationSPDTPEEKIREYFGG
CCCCHHHHHHHHHCC
45.4626320211
197 (in isoform 1)Ubiquitination-45.4621890473
199 (in isoform 2)Ubiquitination-43.5621890473
199 (in isoform 4)Ubiquitination-43.5621890473
201PhosphorylationPEEKIREYFGGFGEV
HHHHHHHHHCCCCCE
9.5527642862
210PhosphorylationGGFGEVESIELPMDN
CCCCCEEEEEECCCC
26.9127732954
215SulfoxidationVESIELPMDNKTNKR
EEEEEECCCCCCCCC
16.1430846556
218MethylationIELPMDNKTNKRRGF
EEECCCCCCCCCCCE
49.5766728815
218AcetylationIELPMDNKTNKRRGF
EEECCCCCCCCCCCE
49.5725953088
218UbiquitinationIELPMDNKTNKRRGF
EEECCCCCCCCCCCE
49.5721890473
218 (in isoform 3)Ubiquitination-49.5721890473
218 (in isoform 1)Ubiquitination-49.5721890473
224 (in isoform 2)Ubiquitination-27.92-
226S-nitrosocysteineTNKRRGFCFITFKEE
CCCCCCEEEEEECCC
2.41-
226GlutathionylationTNKRRGFCFITFKEE
CCCCCCEEEEEECCC
2.4122555962
226S-nitrosylationTNKRRGFCFITFKEE
CCCCCCEEEEEECCC
2.4119483679
231AcetylationGFCFITFKEEEPVKK
CEEEEEECCCCHHHH
56.4125825284
231UbiquitinationGFCFITFKEEEPVKK
CEEEEEECCCCHHHH
56.41-
232AcetylationFCFITFKEEEPVKKI
EEEEEECCCCHHHHH
64.5019608861
232UbiquitinationFCFITFKEEEPVKKI
EEEEEECCCCHHHHH
64.5019608861
237MalonylationFKEEEPVKKIMEKKY
ECCCCHHHHHHHHHH
47.5026320211
237AcetylationFKEEEPVKKIMEKKY
ECCCCHHHHHHHHHH
47.5025953088
238AcetylationKEEEPVKKIMEKKYH
CCCCHHHHHHHHHHH
47.7430583115
241 (in isoform 2)Ubiquitination-50.28-
243AcetylationVKKIMEKKYHNVGLS
HHHHHHHHHHCCCCC
38.1323749302
243UbiquitinationVKKIMEKKYHNVGLS
HHHHHHHHHHCCCCC
38.13-
244PhosphorylationKKIMEKKYHNVGLSK
HHHHHHHHHCCCCCH
15.0828152594
250PhosphorylationKYHNVGLSKCEIKVA
HHHCCCCCHHEEEEE
29.3624961811
251AcetylationYHNVGLSKCEIKVAM
HHCCCCCHHEEEEEE
40.7119608861
251UbiquitinationYHNVGLSKCEIKVAM
HHCCCCCHHEEEEEE
40.7119608861
251 (in isoform 3)Ubiquitination-40.71-
251MalonylationYHNVGLSKCEIKVAM
HHCCCCCHHEEEEEE
40.7126320211
255UbiquitinationGLSKCEIKVAMSKEQ
CCCHHEEEEEECHHH
11.14-
255AcetylationGLSKCEIKVAMSKEQ
CCCHHEEEEEECHHH
11.1425953088
260MethylationEIKVAMSKEQYQQQQ
EEEEEECHHHHHHHH
35.43115479067
260UbiquitinationEIKVAMSKEQYQQQQ
EEEEEECHHHHHHHH
35.43-
260 (in isoform 3)Ubiquitination-35.43-
263PhosphorylationVAMSKEQYQQQQQWG
EEECHHHHHHHHHHH
14.9123917254
263 (in isoform 4)Methylation-14.9124129315
269 (in isoform 4)Phosphorylation-11.4626434776
271PhosphorylationQQQQQWGSRGGFAGR
HHHHHHHCCCCHHHC
25.4523186163
271 (in isoform 4)Phosphorylation-25.4526434776
272DimethylationQQQQWGSRGGFAGRA
HHHHHHCCCCHHHCC
45.36-
272MethylationQQQQWGSRGGFAGRA
HHHHHHCCCCHHHCC
45.3624129315
273 (in isoform 4)Acetylation-36.9519608861
273AcetylationQQQWGSRGGFAGRAR
HHHHHCCCCHHHCCC
36.9519608861
275 (in isoform 4)Phosphorylation-7.8926434776
277MethylationGSRGGFAGRARGRGG
HCCCCHHHCCCCCCC
22.8615782174
278DimethylationSRGGFAGRARGRGGG
CCCCHHHCCCCCCCC
20.06-
278MethylationSRGGFAGRARGRGGG
CCCCHHHCCCCCCCC
20.0624129315
280DimethylationGGFAGRARGRGGGPS
CCHHHCCCCCCCCCC
33.70-
280MethylationGGFAGRARGRGGGPS
CCHHHCCCCCCCCCC
33.7024129315
282DimethylationFAGRARGRGGGPSQN
HHHCCCCCCCCCCCC
34.72-
282MethylationFAGRARGRGGGPSQN
HHHCCCCCCCCCCCC
34.7218583695
282 (in isoform 3)Methylation-34.7224129315
285AcetylationRARGRGGGPSQNWNQ
CCCCCCCCCCCCCCC
22.8519608861
288 (in isoform 3)Phosphorylation-63.1926434776
290 (in isoform 3)Phosphorylation-7.2926434776
292 (in isoform 3)Ubiquitination-43.76-
292 (in isoform 3)Acetylation-43.7619608861
294 (in isoform 3)Phosphorylation-5.5126434776
341AcetylationNQQSGYGKVSRRGGH
CCCCCCCCCCCCCCC
28.6726051181
343PhosphorylationQSGYGKVSRRGGHQN
CCCCCCCCCCCCCCC
21.53-
345Asymmetric dimethylarginineGYGKVSRRGGHQNSY
CCCCCCCCCCCCCCC
48.19-
345MethylationGYGKVSRRGGHQNSY
CCCCCCCCCCCCCCC
48.1924129315
351PhosphorylationRRGGHQNSYKPY---
CCCCCCCCCCCC---
28.1526055452
353MethylationGGHQNSYKPY-----
CCCCCCCCCC-----
37.3519608861
353AcetylationGGHQNSYKPY-----
CCCCCCCCCC-----
37.3519608861

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
83SPhosphorylationKinaseGSK3BP49841
PSP
87SPhosphorylationKinasePRKACAP17612
GPS
87SPhosphorylationKinasePKA-FAMILY-GPS
87SPhosphorylationKinasePKA_GROUP-PhosphoELM
193TPhosphorylationKinaseCDK2P24941
PSP
-KUbiquitinationE3 ubiquitin ligaseVHLP40337
PMID:22086907
-KUbiquitinationE3 ubiquitin ligaseBTRCQ9Y297
PMID:24658274

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
345RMethylation

15782174

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of HNRPD_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
LSM5_HUMANLSM5physical
15231747
SAFB1_HUMANSAFBphysical
10933876
HSPB1_HUMANHSPB1physical
18573886
HSP74_HUMANHSPA4physical
18573886
HSP7C_HUMANHSPA8physical
18573886
IF4G1_HUMANEIF4G1physical
18573886
HNRPD_HUMANHNRNPDphysical
18573886
MTA2_HUMANMTA2physical
18413351
HDAC1_HUMANHDAC1physical
18413351
HSP74_HUMANHSPA4physical
10205060
HSP7C_HUMANHSPA8physical
10205060
IF4G1_HUMANEIF4G1physical
10205060
PABP1_HUMANPABPC1physical
10205060
HSPB1_HUMANHSPB1physical
21245386
HSPB2_HUMANHSPB2physical
21245386
HNRPD_HUMANHNRNPDphysical
21245386
HNRPD_HUMANHNRNPDphysical
12674497
HNRPQ_HUMANSYNCRIPphysical
12674497
YBOX1_HUMANYBX1physical
12674497
IF2B2_HUMANIGF2BP2physical
12674497
UBC9_HUMANUBE2Iphysical
12674497
VHL_HUMANVHLphysical
22086907
VEGFA_HUMANVEGFAphysical
22086907
TNFA_HUMANTNFphysical
22086907
PABP1_HUMANPABPC1physical
22939629
HNRPR_HUMANHNRNPRphysical
22939629
PTBP1_HUMANPTBP1physical
22939629
RBMX_HUMANRBMXphysical
22939629
HNRPF_HUMANHNRNPFphysical
22939629
ROA1_HUMANHNRNPA1physical
22939629
HNRPL_HUMANHNRNPLphysical
22939629
ROA2_HUMANHNRNPA2B1physical
22939629
ROA0_HUMANHNRNPA0physical
22939629
ROA3_HUMANHNRNPA3physical
22939629
RM12_HUMANMRPL12physical
22939629
RS28_HUMANRPS28physical
22939629
RALY_HUMANRALYphysical
22939629
RMD3_HUMANRMDN3physical
22939629
SEPT9_HUMANSEPT9physical
22939629
ZNT5_HUMANSLC30A5physical
22939629
MSH2_HUMANMSH2physical
22939629
HNRPD_HUMANHNRNPDphysical
16556936
IF4G1_HUMANEIF4G1physical
16556936
PABP1_HUMANPABPC1physical
16556936
HSP74_HUMANHSPA4physical
16556936
1433S_HUMANSFNphysical
16902409
PABP1_HUMANPABPC1physical
16902409
RU1C_HUMANSNRPCphysical
22365833
SF3B4_HUMANSF3B4physical
22365833
U2AF2_HUMANU2AF2physical
22365833
HNRPC_HUMANHNRNPCphysical
22365833
RALY_HUMANRALYphysical
22365833
HNRPU_HUMANHNRNPUphysical
22365833
HNRPK_HUMANHNRNPKphysical
22365833
HNRPF_HUMANHNRNPFphysical
22365833
HNRH3_HUMANHNRNPH3physical
22365833
PTBP1_HUMANPTBP1physical
22365833
PTBP2_HUMANPTBP2physical
22365833
IL7RA_HUMANIL7Rphysical
23151878
BRCA1_HUMANBRCA1physical
22431556
HMGA1_HUMANHMGA1physical
18850631
C1QBP_HUMANC1QBPphysical
15231747
RSSA_HUMANRPSAphysical
15231747
ACTB_HUMANACTBphysical
15231747
TF3C3_HUMANGTF3C3physical
15231747
CD97_HUMANCD97physical
15231747
EXOS4_HUMANEXOSC4physical
15231747
EF2_HUMANEEF2physical
15231747
SNPC4_HUMANSNAPC4physical
15231747
MRP7_HUMANABCC10physical
15231747
BET1L_HUMANBET1Lphysical
15231747
SEN34_HUMANTSEN34physical
15231747
CINP_HUMANCINPphysical
15231747
SHSA5_HUMANSHISA5physical
15231747
EM55_HUMANMPP1physical
15231747
DMAC1_HUMANTMEM261physical
15231747
KGUA_HUMANGUK1physical
15231747
PDIA1_HUMANP4HBphysical
15231747
FLNA_HUMANFLNAphysical
15231747
ARF4_HUMANARF4physical
15231747
4F2_HUMANSLC3A2physical
15231747
MP2K1_HUMANMAP2K1physical
15231747
HIRA_HUMANHIRAphysical
15231747
CD81_HUMANCD81physical
15231747
IDD_HUMANDGCR2physical
15231747
CAN1_HUMANCAPN1physical
15231747
HBAZ_HUMANHBZphysical
15231747
PDLI7_HUMANPDLIM7physical
15231747
SEPT9_HUMANSEPT9physical
15231747
MIC60_HUMANIMMTphysical
15231747
P5CR1_HUMANPYCR1physical
15231747
BRCA1_HUMANBRCA1physical
15231747
S27A5_HUMANSLC27A5physical
15231747
NTM1A_HUMANNTMT1physical
15231747
DHX30_HUMANDHX30physical
15231747
CUTA_HUMANCUTAphysical
15231747
GTSE1_HUMANGTSE1physical
15231747
FXL15_HUMANFBXL15physical
15231747
COIA1_HUMANCOL18A1physical
15231747
IMP2L_HUMANIMMP2Lphysical
15231747
COG7_HUMANCOG7physical
15231747
PPOX_HUMANPPOXphysical
15231747
CATB_HUMANCTSBphysical
15231747
PEX10_HUMANPEX10physical
15231747
QCR1_HUMANUQCRC1physical
15231747
PRDX3_HUMANPRDX3physical
15231747
SDF2_HUMANSDF2physical
15231747
B3GA3_HUMANB3GAT3physical
15231747
EIF3K_HUMANEIF3Kphysical
22863883
RS12_HUMANRPS12physical
22863883
WNK1_HUMANWNK1physical
22863883
STAU1_HUMANSTAU1physical
23125841
NUCL_HUMANNCLphysical
16571724
KAT2B_HUMANKAT2Bphysical
15834135
ING4_HUMANING4physical
23603392
MYC_HUMANMYCphysical
23603392
CUL2_HUMANCUL2physical
22086907
VEGFA_HUMANVEGFAphysical
23109422
PGH2_HUMANPTGS2physical
23109422
CHK1_HUMANCHEK1physical
26344197
DNJC7_HUMANDNAJC7physical
26344197
ROA3_HUMANHNRNPA3physical
26344197
ROAA_HUMANHNRNPABphysical
26344197
PCBP1_HUMANPCBP1physical
26344197
PGK1_HUMANPGK1physical
26344197
BLMH_HUMANBLMHphysical
26496610
MCAT_HUMANSLC25A20physical
26496610
CETN2_HUMANCETN2physical
26496610
DKC1_HUMANDKC1physical
26496610
DYN2_HUMANDNM2physical
26496610
IF4G1_HUMANEIF4G1physical
26496610
ETFA_HUMANETFAphysical
26496610
FACD2_HUMANFANCD2physical
26496610
ACSL4_HUMANACSL4physical
26496610
MTOR_HUMANMTORphysical
26496610
GOGA4_HUMANGOLGA4physical
26496610
HEXA_HUMANHEXAphysical
26496610
ROA2_HUMANHNRNPA2B1physical
26496610
ROAA_HUMANHNRNPABphysical
26496610
HNRPC_HUMANHNRNPCphysical
26496610
HNRPK_HUMANHNRNPKphysical
26496610
HNRPU_HUMANHNRNPUphysical
26496610
DHB4_HUMANHSD17B4physical
26496610
HSP76_HUMANHSPA6physical
26496610
ITB4_HUMANITGB4physical
26496610
IF6_HUMANEIF6physical
26496610
M3K4_HUMANMAP3K4physical
26496610
MYH1_HUMANMYH1physical
26496610
NHS_HUMANNHSphysical
26496610
YBOX1_HUMANYBX1physical
26496610
PHLP_HUMANPDCLphysical
26496610
PLXB1_HUMANPLXNB1physical
26496610
PPM1A_HUMANPPM1Aphysical
26496610
RBM4_HUMANRBM4physical
26496610
RET_HUMANRETphysical
26496610
SRSF6_HUMANSRSF6physical
26496610
UAP1_HUMANUAP1physical
26496610
TARB1_HUMANTARBP1physical
26496610
GCFC2_HUMANGCFC2physical
26496610
TLN1_HUMANTLN1physical
26496610
TNR1A_HUMANTNFRSF1Aphysical
26496610
BAG6_HUMANBAG6physical
26496610
UBP11_HUMANUSP11physical
26496610
DYSF_HUMANDYSFphysical
26496610
NRP1_HUMANNRP1physical
26496610
TAXB1_HUMANTAX1BP1physical
26496610
FUBP3_HUMANFUBP3physical
26496610
GT2D1_HUMANGTF2IRD1physical
26496610
ESPL1_HUMANESPL1physical
26496610
RHG32_HUMANARHGAP32physical
26496610
C2CD5_HUMANC2CD5physical
26496610
OSBL2_HUMANOSBPL2physical
26496610
RBM8A_HUMANRBM8Aphysical
26496610
ANM3_HUMANPRMT3physical
26496610
SAP18_HUMANSAP18physical
26496610
ABCA7_HUMANABCA7physical
26496610
TBB3_HUMANTUBB3physical
26496610
PPIH_HUMANPPIHphysical
26496610
HNRPQ_HUMANSYNCRIPphysical
26496610
SRS10_HUMANSRSF10physical
26496610
COG2_HUMANCOG2physical
26496610
FND3A_HUMANFNDC3Aphysical
26496610
MORC2_HUMANMORC2physical
26496610
DHX30_HUMANDHX30physical
26496610
F120A_HUMANFAM120Aphysical
26496610
UBP24_HUMANUSP24physical
26496610
ECM29_HUMANKIAA0368physical
26496610
DICER_HUMANDICER1physical
26496610
SIR5_HUMANSIRT5physical
26496610
KLDC2_HUMANKLHDC2physical
26496610
INT7_HUMANINTS7physical
26496610
PKN3_HUMANPKN3physical
26496610
PLPL8_HUMANPNPLA8physical
26496610
CHMP5_HUMANCHMP5physical
26496610
URFB1_HUMANUHRF1BP1physical
26496610
RAIN_HUMANRASIP1physical
26496610
PINX1_HUMANPINX1physical
26496610
HEAT3_HUMANHEATR3physical
26496610
P4R3B_HUMANSMEK2physical
26496610
Z286A_HUMANZNF286Aphysical
26496610
GPBP1_HUMANGPBP1physical
26496610
PDRG1_HUMANPDRG1physical
26496610
MTMRD_HUMANSBF2physical
26496610
TLN2_HUMANTLN2physical
26496610
KLF16_HUMANKLF16physical
26496610
OBSCN_HUMANOBSCNphysical
26496610
WDR24_HUMANWDR24physical
26496610
GRIN1_HUMANGPRIN1physical
26496610
RM55_HUMANMRPL55physical
26496610
PTGR2_HUMANPTGR2physical
26496610
PPR18_HUMANPPP1R18physical
26496610
DDX51_HUMANDDX51physical
26496610
HNRC1_HUMANHNRNPCL1physical
26496610
FBW1A_HUMANBTRCphysical
23530064
HSPB1_HUMANHSPB1physical
23530064

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of HNRPD_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-165; LYS-251; LYS-341 ANDLYS-353, AND MASS SPECTROMETRY.
Methylation
ReferencePubMed
"Identifying and quantifying in vivo methylation sites by heavy methylSILAC.";
Ong S.E., Mittler G., Mann M.;
Nat. Methods 1:119-126(2004).
Cited for: METHYLATION [LARGE SCALE ANALYSIS] AT ARG-345, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82; SER-190 AND THR-193,AND MASS SPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80 AND SER-83, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-190 AND THR-193, ANDMASS SPECTROMETRY.
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography.";
Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.;
Proteomics 8:1346-1361(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82; SER-83; SER-190 ANDTHR-193, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83 AND THR-193, AND MASSSPECTROMETRY.
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment.";
Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
J. Proteome Res. 7:5167-5176(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80, AND MASSSPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80; SER-82; SER-83;SER-87 AND THR-91, AND MASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-190, AND MASSSPECTROMETRY.
"Quantitative phosphoproteome analysis using a dendrimer conjugationchemistry and tandem mass spectrometry.";
Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J.,Bodenmiller B., Watts J.D., Hood L., Aebersold R.;
Nat. Methods 2:591-598(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-190 AND THR-193, ANDMASS SPECTROMETRY.

TOP